George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.44
Bid: 41.60
Ask: 41.70
Change: 0.56 (1.37%)
Spread: 0.10 (0.24%)
Open: 41.36
High: 41.70
Low: 40.84
Prev. Close: 40.88
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Jan 2020 07:00

RNS Number : 5048Z
Assura PLC
13 January 2020
 

13 January 2020

Assura plc

 

Trading Update

For the third quarter ending 31 December 2019

 

Continued strong performance

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the third quarter ending 31 December 2019.

 

Jonathan Murphy, CEO, said:

 

"Assura continued to make strong progress in the third quarter. We expanded our market-leading portfolio with the acquisition of six high-quality assets and completed our third development of the year in Stow-on-the-Wold. We also grew our immediate pipeline of acquisition and development opportunities, reinforcing what was already our strongest in 10 years, to £252 million including 13 developments currently on site."

 

"With the new Government enshrining in law increased funding for the NHS and taking forward the Health Infrastructure Plan, better primary care facilities for patients, staff and services are at the heart of the agenda. In this context, Assura is well positioned to deliver high-quality assets and value for money for the NHS."

 

Building the portfolio

·; Current portfolio of 563 properties.

·; Development completed at Stow-on-the-Wold, taking total to three completed year to date at a total cost of £11.8 million.

·; Currently on site with 13 developments at the period end with a total development cost of £66 million.

·; Six acquisitions completed in the period at a cost of £31.1 million; four disposals made for cash proceeds of £1.0 million.

 

Expanding the pipeline

·; Immediate development pipeline further increased to £90 million, up from £72 million at September 2019.

·; Immediate acquisitions pipeline further increased to £96 million, up from £65 million at September 2019.

·; Total immediate pipeline, including on site developments, worth £252 million, up from £206 million at September 2019.

 

Growing the rent roll

·; Five lease re-gears completed in the quarter taking cumulative year-to-date re-gears to 18. These leases represent £1.7 million of the Group's rent roll, adding a weighted average of 10.2 years WAULT to those 18 leases.

·; Annualised rent roll at £105.8 million taking account of additions, disposals and rent reviews.

 

Robust balance sheet

·; As at 31 December 2019 gross debt stood at £787 million with undrawn facilities of £280 million.

 

As previously announced, the quarterly dividend has been increased to 0.697 pence per share with effect from January 2020. This is equivalent to 2.788 pence per share on an annualised basis.

 

ENDS

 

 

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERLEIILII
Date   Source Headline
18th Nov 20219:42 amRNSHolding(s) in Company
16th Nov 20215:22 pmRNSHolding(s) in Company
15th Nov 20219:52 amRNSDirector/PDMR Shareholding
11th Nov 20214:32 pmRNSResult of Placing
11th Nov 20217:01 amRNSPrimaryBid offer
11th Nov 20217:00 amRNSProposed equity placing of new ordinary shares
11th Nov 20217:00 amRNSInterim Results 2021
9th Nov 202112:07 pmRNSDirector/PDMR Shareholding
8th Nov 20214:04 pmRNSHolding(s) in Company
5th Nov 20217:00 amRNSInvestor Presentation
29th Oct 20217:00 amRNSNotice of Interim Results
29th Oct 20217:00 amRNSTotal Voting Rights
27th Oct 20213:51 pmRNSHolding(s) in Company
25th Oct 20217:58 amRNSIssue of Consideration Shares
19th Oct 20214:15 pmRNSDirector/PDMR Shareholding
13th Oct 20212:31 pmRNSAppointment of Joint Corporate Broker
11th Oct 20217:00 amRNSScrip Dividend Declaration
7th Oct 20219:14 amRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSTrading Update
4th Oct 20212:58 pmRNSHolding(s) in Company
21st Sep 20217:00 amRNSHolding(s) in Company
20th Sep 20214:44 pmRNSHolding(s) in Company
17th Sep 20219:33 amRNSScrip Calculation Price
16th Sep 20214:27 pmRNSHolding(s) in Company
14th Sep 20214:15 pmRNSHolding(s) in Company
13th Sep 20219:08 amRNSHolding(s) in Company
7th Sep 20219:02 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSNotice of Dividend
6th Aug 20219:24 amRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSReduction of RCF
28th Jul 20214:23 pmRNSHolding(s) in Company
26th Jul 20215:30 pmRNSHolding(s) in Company
26th Jul 20218:57 amRNSHolding(s) in Company
20th Jul 20211:56 pmRNSDirector/PDMR Shareholding
15th Jul 20219:56 amRNSExercise of Nil Cost Options under PSP
12th Jul 20211:00 pmRNSScrip Dividend Declaration
8th Jul 202112:20 pmRNSDirector/PDMR Shareholding
8th Jul 202110:08 amRNSDirector/PDMR Shareholding
6th Jul 20212:15 pmRNSResult of AGM
6th Jul 202111:39 amRNSAdditional Listing
6th Jul 20217:00 amRNSTrading Update
28th Jun 20211:02 pmRNSHolding(s) in Company
23rd Jun 20214:01 pmRNSPricing of £300m Sustainability Bond
22nd Jun 20215:05 pmRNSHolding(s) in Company
17th Jun 20219:52 amRNSScrip Calculation Price
15th Jun 20213:30 pmRNSHolding(s) in Company
11th Jun 20215:24 pmRNSHolding(s) in Company
10th Jun 20213:03 pmRNSHolding(s) in Company
8th Jun 20214:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.